GF Fund Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.38K Hold
1,594
﹤0.01% 612
2025
Q1
$5.07K Buy
1,594
+245
+18% +$779 ﹤0.01% 623
2024
Q4
$7.22K Buy
+1,349
New +$7.22K ﹤0.01% 584